Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feorillo Galivo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
Is a β cell a β cell?Chaoxing Yang, Feorillo Galivo, Craig Dorrell
Stem Cell Research|November 12, 2016
Efficient generation of pancreatic β-like cells from the mouse gallbladderYuhan Wang, Feorillo Galivo, Carl Pelz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signalingPhonphimon Wongthida, Rosa M Diaz, Feorillo Galivo, et al.
Plos One|August 17, 2017
Reprogramming human gallbladder cells into insulin-producing β-like cellsFeorillo Galivo, Eric Benedetti, Yuhan Wang, et al.
Cancer Research|March 17, 2007
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virusRosa Maria Diaz, Feorillo Galivo, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideCandice Willmon, Rosa M Diaz, Phonphimon Wongthida, et al.
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2018
Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic DuctsYuhan Wang, Craig Dorrell, Willscott E Naugler, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Human Gene Therapy|March 17, 2022
Development of a Beta Cell-Specific Expression Control Element for Recombinant Adeno-Associated VirusSunghee Chai, Youngjin Kim, Feorillo Galivo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
Is a β cell a β cell?Chaoxing Yang, Feorillo Galivo, Craig Dorrell
Stem Cell Research|November 12, 2016
Efficient generation of pancreatic β-like cells from the mouse gallbladderYuhan Wang, Feorillo Galivo, Carl Pelz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signalingPhonphimon Wongthida, Rosa M Diaz, Feorillo Galivo, et al.
Plos One|August 17, 2017
Reprogramming human gallbladder cells into insulin-producing β-like cellsFeorillo Galivo, Eric Benedetti, Yuhan Wang, et al.
Cancer Research|March 17, 2007
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virusRosa Maria Diaz, Feorillo Galivo, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideCandice Willmon, Rosa M Diaz, Phonphimon Wongthida, et al.
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2018
Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic DuctsYuhan Wang, Craig Dorrell, Willscott E Naugler, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Human Gene Therapy|March 17, 2022
Development of a Beta Cell-Specific Expression Control Element for Recombinant Adeno-Associated VirusSunghee Chai, Youngjin Kim, Feorillo Galivo, et al.
Pageof 2